Back to Awarded Treatment Trials
Awarded Trial: 01-069
Magnetic Seizure Therapy (MST)
Suprathreshold dose for seizures
Secondary Drug Intervention
Duration of Study Period for Each Subject
CFQ, MMSE, SRT, AMI, HRSD
Twenty medication resistant patients referred for electroconvulsive therapy received magnetic seizure therapy under controlled conditions. Sixty percent of patients experienced a 50% drop in depression ratings and 35% had a complete remission. The efficacy of MST was equivalent to that reported in the literature for ECT. Moreover, there were fewer cognitive side effects with MST.
Research Foundation for Mental Hygiene, Inc.
New York Psychiatric Institute Division
1051 Riverside Drive
City or Town
State or Province
Zip or Postal Code